JP2015516950A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015516950A5 JP2015516950A5 JP2015502460A JP2015502460A JP2015516950A5 JP 2015516950 A5 JP2015516950 A5 JP 2015516950A5 JP 2015502460 A JP2015502460 A JP 2015502460A JP 2015502460 A JP2015502460 A JP 2015502460A JP 2015516950 A5 JP2015516950 A5 JP 2015516950A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmacologically active
- pharmaceutical composition
- active material
- acoustic
- additive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1205632.1A GB201205632D0 (en) | 2012-03-30 | 2012-03-30 | Method and apparatus |
| GB1205632.1 | 2012-03-30 | ||
| PCT/GB2013/050847 WO2013144655A1 (en) | 2012-03-30 | 2013-03-28 | Method and apparatus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015516950A JP2015516950A (ja) | 2015-06-18 |
| JP2015516950A5 true JP2015516950A5 (enExample) | 2016-05-26 |
Family
ID=46159980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015502460A Pending JP2015516950A (ja) | 2012-03-30 | 2013-03-28 | 方法と装置 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20150059746A1 (enExample) |
| EP (1) | EP2830751A1 (enExample) |
| JP (1) | JP2015516950A (enExample) |
| KR (1) | KR20140142264A (enExample) |
| CN (1) | CN104203385A (enExample) |
| AU (1) | AU2013239409A1 (enExample) |
| CA (1) | CA2867097A1 (enExample) |
| GB (1) | GB201205632D0 (enExample) |
| HK (1) | HK1206670A1 (enExample) |
| IL (1) | IL234659A0 (enExample) |
| IN (1) | IN2014DN08753A (enExample) |
| MX (1) | MX2014011795A (enExample) |
| NZ (1) | NZ629920A (enExample) |
| RU (1) | RU2014143807A (enExample) |
| SG (2) | SG11201405555RA (enExample) |
| WO (1) | WO2013144655A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9107851B2 (en) | 2012-10-15 | 2015-08-18 | New Jersey Institute Of Technology | Solventless mixing process for coating pharmaceutical ingredients |
| JP2015537025A (ja) * | 2012-11-16 | 2015-12-24 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | 音響混合技術を使用して集塊物を作製するためのプロセス |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| CN105473133A (zh) | 2013-04-30 | 2016-04-06 | 欧缇托匹克公司 | 干粉制剂及使用方法 |
| US20160235667A1 (en) * | 2013-10-02 | 2016-08-18 | Vectura Limited | Method and apparatus for making compositions for pulmonary administration |
| GB201321712D0 (en) * | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Dry Powder Inhaler |
| US20160317391A1 (en) * | 2013-12-17 | 2016-11-03 | Merck Sharp & Dohme Corp. | Media milling process for the manufacture of active pharmaceutical ingredients in propellants |
| ES2701525T3 (es) | 2014-07-09 | 2019-02-22 | Arven Ilac Sanayi Ve Ticaret As | Un procedimiento para la preparación de formulaciones para inhalación |
| SG11201700536XA (en) | 2014-09-09 | 2017-02-27 | Vectura Ltd | Formulation comprising glycopyrrolate, method and apparatus |
| EA201792159A1 (ru) | 2015-04-01 | 2018-01-31 | Люпин Атлантис Холдингс Са | Способ получения сухих порошкообразных смесей |
| US9968223B2 (en) | 2015-06-12 | 2018-05-15 | Sunbeam Products, Inc. | Blending appliance with paddle blade |
| HK1247150A1 (zh) * | 2015-07-07 | 2018-09-21 | Abbvie Inc. | 用声学混合自动造粒 |
| JPWO2017047650A1 (ja) * | 2015-09-14 | 2018-06-28 | 大和製罐株式会社 | 粉末吸入剤、吸入器、及び粉末吸入剤の製造方法 |
| EP3684338A4 (en) | 2017-09-22 | 2021-06-23 | Otitopic Inc. | DRY POWDER COMPOSITIONS WITH MAGNESIUM STEARATE |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| US11642333B2 (en) * | 2019-05-23 | 2023-05-09 | Anovent Pharmaceutical (U.S.), Llc | Inhalable formulation of a solution containing vilanterol trifenatate and umeclidinium bromide |
| CN111297837B (zh) * | 2020-03-26 | 2022-02-22 | 上海方予健康医药科技有限公司 | 一种干粉吸入剂的制备方法 |
| CN113144997B (zh) * | 2021-03-23 | 2022-10-25 | 西安近代化学研究所 | 共振声混合中临界波动率确定、混合均匀性判定方法及系统 |
| KR102796431B1 (ko) * | 2021-09-17 | 2025-04-16 | 주식회사 케이티앤지 | 흡연 물품 및 에어로졸 발생 시스템 |
| US12157098B2 (en) * | 2021-12-14 | 2024-12-03 | Honeywell Federal Manufacturing & Technologies, Llc | Resonant acoustic mixing system and method |
| US20250235399A1 (en) * | 2022-04-07 | 2025-07-24 | Board Of Regents, The University Of Texas System | Methods of preparing carrier-based dry powders for inhalation |
| EP4531809A2 (en) * | 2022-05-28 | 2025-04-09 | Avalyn Pharma Inc. | Nintedanib and nintedanib combination dry powder compositions and uses |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996025918A1 (en) * | 1995-02-24 | 1996-08-29 | Nanosystems L.L.C. | Aerosols containing nanoparticle dispersions |
| US20070212422A1 (en) * | 1999-11-10 | 2007-09-13 | Manfred Keller | Dry powder for inhalation |
| JP2004533917A (ja) * | 2001-05-01 | 2004-11-11 | グラクソ グループ リミテッド | 解塊装置および方法 |
| GB0205327D0 (en) * | 2002-03-06 | 2002-04-17 | Glaxo Group Ltd | compounds |
| US8501232B2 (en) * | 2002-04-23 | 2013-08-06 | Nanotherapeutics, Inc. | Process of forming and modifying particles and compositions produced thereby |
| US7188993B1 (en) * | 2003-01-27 | 2007-03-13 | Harold W Howe | Apparatus and method for resonant-vibratory mixing |
| US20060152998A1 (en) * | 2003-09-10 | 2006-07-13 | Burr Ronald F | Acoustic fluidized bed |
| GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| GB0605676D0 (en) * | 2006-03-22 | 2006-05-03 | Vectura Ltd | Improvements in extraction of powder formulations |
| EP2082767A1 (en) * | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| WO2009158300A1 (en) * | 2008-06-26 | 2009-12-30 | 3M Innovative Properties Company | Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof |
| CN102149437B (zh) * | 2008-07-18 | 2017-02-15 | 普罗索尼克斯有限公司 | 用于提高氟替卡松颗粒结晶度的方法 |
| HUE038555T2 (hu) * | 2010-04-21 | 2018-10-29 | Chiesi Farm Spa | Eljárás csökkentett elektrosztatikus töltéssel rendelkezõ részecskék elõállítására |
| WO2011136363A1 (ja) | 2010-04-28 | 2011-11-03 | 三洋電機株式会社 | 回路装置の製造方法 |
| US9763965B2 (en) * | 2012-04-13 | 2017-09-19 | Glaxosmithkline Intellectual Property Development Limited | Aggregate particles |
| JP2015537025A (ja) * | 2012-11-16 | 2015-12-24 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | 音響混合技術を使用して集塊物を作製するためのプロセス |
-
2012
- 2012-03-30 GB GBGB1205632.1A patent/GB201205632D0/en not_active Ceased
-
2013
- 2013-03-28 SG SG11201405555RA patent/SG11201405555RA/en unknown
- 2013-03-28 JP JP2015502460A patent/JP2015516950A/ja active Pending
- 2013-03-28 MX MX2014011795A patent/MX2014011795A/es unknown
- 2013-03-28 CN CN201380016626.5A patent/CN104203385A/zh active Pending
- 2013-03-28 US US14/387,629 patent/US20150059746A1/en not_active Abandoned
- 2013-03-28 AU AU2013239409A patent/AU2013239409A1/en not_active Abandoned
- 2013-03-28 WO PCT/GB2013/050847 patent/WO2013144655A1/en not_active Ceased
- 2013-03-28 RU RU2014143807A patent/RU2014143807A/ru not_active Application Discontinuation
- 2013-03-28 NZ NZ629920A patent/NZ629920A/en not_active IP Right Cessation
- 2013-03-28 HK HK15107349.6A patent/HK1206670A1/xx unknown
- 2013-03-28 CA CA2867097A patent/CA2867097A1/en not_active Abandoned
- 2013-03-28 KR KR1020147027247A patent/KR20140142264A/ko not_active Withdrawn
- 2013-03-28 EP EP13715413.4A patent/EP2830751A1/en not_active Withdrawn
- 2013-03-28 SG SG10201608088YA patent/SG10201608088YA/en unknown
-
2014
- 2014-09-15 IL IL234659A patent/IL234659A0/en unknown
- 2014-10-17 IN IN8753DEN2014 patent/IN2014DN08753A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7462645B2 (en) | Bronchodilating beta-agonist compositions and methods | |
| NZ629920A (en) | A method for making an inhalable pharmaceutical composition using a resonant acoustic blender | |
| JP2020079295A (ja) | ロフルミラストｎ−酸化物の吸入によって自己免疫、呼吸器性および炎症性の障害を処置する方法 | |
| IL143986A (en) | Combinations of formotrol and tiotropium salt | |
| JP2013542940A5 (enExample) | ||
| JP2015519356A5 (enExample) | ||
| AR075516A1 (es) | Composicion farmaceutica para inhalacion | |
| NZ627837A (en) | Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation | |
| JP2013531056A5 (enExample) | ||
| EP2682108A3 (en) | Dry Powder Inhalers Comprising a Carrier Other Than Lactose and a Ternary Component | |
| JP2017039746A (ja) | 医薬組成物 | |
| JP2019528316A5 (enExample) | ||
| EP2682097A3 (en) | Dry Powder Inhalers Comprising A Carrier Other Than Lactose | |
| WO2015116856A3 (en) | Farnesoid x receptor antagonists | |
| JOP20200314A1 (ar) | تركيبات صيدلانية مستقرة لأجهزة إستنشاق جرعات مضغوطة معايرة الجرعة | |
| MX2018014425A (es) | Beta-horquilla peptidomimetica con actividad inhibidora de elastasa y formas de dosificacion en aerosol de la misma. | |
| WO2015049519A3 (en) | Method and apparatus for making compositions for pulmonary administration | |
| WO2016071862A1 (en) | Inhalable pharmaceutical composition comprising glycopyrronium | |
| EP4616915A3 (en) | Ecopipam for treatment of tourettes syndrome | |
| KR20180101438A (ko) | 7-아조니아바이사이클로[2.2.1]헵탄 유도체의 건조 분말 흡입기 조성물 | |
| WO2017077488A1 (en) | An inhalable fixed dose powder composition comprising glycopyrronium and formoterol | |
| Chapman et al. | Pharmacology of SCH900182, a potent, selective inhibitor of PDE4 for inhaled administration | |
| Siler et al. | Tolerability of Revefenacin and Formoterol Via Nebulization in Patients With Moderate to Very Severe COPD: A Subgroup Analysis of a Phase 3 Trial | |
| MX372705B (es) | Composición farmacéutica que contiene budesonida y formoterol | |
| Rabe et al. | Benefits of tiotropium versus placebo for delaying clinically significant events in patients with moderate COPD (GOLD 2) |